日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Evaluating the Feasibility of Electronic Patient-Reported Outcomes for a Population Receiving Specific Health Checkups: A Pilot Study

评估电子患者报告结果在接受特定健康检查人群中的可行性：一项试点研究

期刊:Healthcare
影响因子:2.7
doi:10.3390/healthcare14020218
Yano, Hiroshi; Hosogaya, Naoki; Ide, Shotaro; Kawasaki, Rina; Tadami, Tokuma; Ide, Masatoshi; Murotani, Kenta
发表日期：2026
文献求助 收藏

A phase I clinical trial to evaluate the tolerability and safety of an allogeneic iPSC-derived iNKT cell and α-GalCer-pulsed autologous DC combination therapy for patients with recurrent and advanced head and neck cancer: A study protocol

一项评估异体iPSC衍生iNKT细胞联合α-GalCer脉冲自体DC治疗复发性和晚期头颈癌患者的耐受性和安全性的I期临床试验：研究方案

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0342387
Kurokawa, Tomoya; Iinuma, Tomohisa; Ebisu, Haruna; Yanagidaira, Tomoha; Inaba, Yosuke; Fujiwara, Tadami; Hattori, Yoko; Fukazawa, Tominaga; Aoki, Takahiro; Koseki, Haruhiko; Hanaoka, Hideki; Hanazawa, Toyoyuki; Motohashi, Shinichiro
肿瘤
T细胞
肿瘤免疫
T细胞
头颈癌
细胞生物学
免疫/内分泌
发表日期：2026
文献求助 收藏

A Phase Ib Study of Durvalumab (MEDI4736) in Combination with Carbon-Ion Radiotherapy and Weekly Cisplatin for Patients with Locally Advanced Cervical Cancer (DECISION Study): The Early Safety and Efficacy Results

Durvalumab (MEDI4736) 联合碳离子放射疗法和每周顺铂治疗局部晚期宫颈癌患者的 Ib 期研究（DECISION 研究）：早期安全性和有效性结果

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms241310565
Okonogi, Noriyuki; Murata, Kazutoshi; Yamada, Shigeru; Habu, Yuji; Hori, Makoto; Kurokawa, Tomoya; Inaba, Yosuke; Fujiwara, Tadami; Fujii, Yasuhisa; Hanawa, Michiko; Kawasaki, Yohei; Hattori, Yoko; Suzuki, Kazuko; Tsuyuki, Kyoko; Wakatsuki, Masaru; Koto, Masashi; Hasegawa, Sumitaka; Ishikawa, Hitoshi; Hanaoka, Hideki; Shozu, Makio; Tsuji, Hiroshi; Usui, Hirokazu
宫颈癌
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Exploratory clinical trial to evaluate the efficacy and safety of transdermal electrical stimulation in patients with central retinal artery occlusion

一项探索性临床试验，旨在评估经皮电刺激治疗中心性视网膜动脉阻塞患者的疗效和安全性。

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0282003
Miura, Gen; Fujiwara, Tadami; Iwase, Takayuki; Ozawa, Yoshihito; Shiko, Yuki; Kawasaki, Yohei; Nizawa, Tomohiro; Tatsumi, Tomoaki; Baba, Takayuki; Kurimoto, Takuji; Mori, Sotaro; Nakamura, Makoto; Hanaoka, Hideki; Yamamoto, Shuichi
发表日期：2023
文献求助 收藏

Efficacy and safety of transdermal electrical stimulation in patients with nonarteritic anterior ischemic optic neuropathy

经皮电刺激治疗非动脉炎性前部缺血性视神经病变的疗效和安全性

期刊:Bioelectronic Medicine
影响因子:
doi:10.1186/s42234-023-00125-2
Miura, Gen; Fujiwara, Tadami; Ozawa, Yoshihito; Shiko, Yuki; Kawasaki, Yohei; Nizawa, Tomohiro; Tatsumi, Tomoaki; Kurimoto, Takuji; Mori, Sotaro; Nakamura, Makoto; Hanaoka, Hideki; Baba, Takayuki; Yamamoto, Shuichi
发表日期：2023
文献求助 收藏

Evaluating the efficacy and safety of transdermal electrical stimulation on the visual functions of patients with retinitis pigmentosa: a clinical trial protocol for a prospective, multicentre, randomised, double-masked and sham-controlled design (ePICO trial)

评估经皮电刺激对视网膜色素变性患者视觉功能的疗效和安全性：一项前瞻性、多中心、随机、双盲、假对照设计的临床试验方案（ePICO 试验）

期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2021-057193
Miura, Gen; Ozawa, Yoshihito; Shiko, Yuki; Kawasaki, Yohei; Iwase, Takayuki; Fujiwara, Tadami; Baba, Takayuki; Hanaoka, Hideki; Yamamoto, Shuichi
发表日期：2022
文献求助 收藏

Phase Ib study of durvalumab (MEDI4736) in combination with carbon-ion radiotherapy and weekly cisplatin for patients with locally advanced cervical cancer (DECISION study): study protocol for a prospective open-label single-arm study

度伐利尤单抗（MEDI4736）联合碳离子放射治疗和每周顺铂治疗局部晚期宫颈癌患者的Ib期研究（DECISION研究）：一项前瞻性开放标签单臂研究的研究方案

期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2021-056424
Okonogi, Noriyuki; Usui, Hirokazu; Murata, Kazutoshi; Hori, Makoto; Kurokawa, Tomoya; Fujiwara, Tadami; Fujii, Yasuhisa; Hanawa, Michiko; Kawasaki, Yohei; Hattori, Yoko; Suzuki, Kazuko; Tsuyuki, Kyoko; Wakatsuki, Masaru; Hasegawa, Sumitaka; Yamada, Shigeru; Hanaoka, Hideki; Shozu, Makio; Tsuji, Hiroshi
宫颈癌
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Phase I study of vorinostat with gefitinib in BIM deletion polymorphism/epidermal growth factor receptor mutation double-positive lung cancer

伏立诺他联合吉非替尼治疗BIM缺失多态性/表皮生长因子受体突变双阳性肺癌的I期研究

期刊:Cancer Science
影响因子:4.3
doi:10.1111/cas.14260
Takeuchi, Shinji; Hase, Tetsunari; Shimizu, Shinobu; Ando, Masahiko; Hata, Akito; Murakami, Haruyasu; Kawakami, Takahiro; Nagase, Katsuhiko; Yoshimura, Kenichi; Fujiwara, Tadami; Tanimoto, Azusa; Nishiyama, Akihiro; Arai, Sachiko; Fukuda, Koji; Katakami, Nobuyuki; Takahashi, Toshiaki; Hasegawa, Yoshinori; Ko, Tun Kiat; Ong, S Tiong; Yano, Seiji
肺癌
信号转导
肿瘤
肿瘤免疫
发表日期：2020
文献求助 收藏

HAMAMATSU-ICG study: Protocol for a phase III, multicentre, single-arm study to assess the usefulness of indocyanine green fluorescent lymphography in assessing secondary lymphoedema

HAMAMATSU-ICG 研究：一项评估吲哚菁绿荧光淋巴造影在继发性淋巴水肿评估中应用价值的 III 期、多中心、单臂研究方案

期刊:Contemporary Clinical Trials Communications
影响因子:1.4
doi:10.1016/j.conctc.2020.100595
Akita, Shinsuke; Unno, Naoki; Maegawa, Jiro; Kimata, Yoshihiro; Fukamizu, Hidekazu; Yabuki, Yuichiro; Shinaoka, Akira; Sano, Masaki; Kawasaki, Yohei; Fujiwara, Tadami; Hanaoka, Hideki; Mitsukawa, Nobuyuki
IF
发表日期：2020
文献求助 收藏

Development of novel diagnostic system for pancreatic cancer, including early stages, measuring mRNA of whole blood cells

开发一种新型胰腺癌诊断系统，包括早期胰腺癌诊断，该系统通过测量全血细胞的mRNA来实现。

期刊:Cancer Science
影响因子:4.5
doi:10.1111/cas.13971.
Yoshio Sakai ,Masao Honda ,Shigeyuki Matsui ,Osamu Komori ,Toshinori Murayama ,Tadami Fujiwara ,Masaaki Mizuno ,Yasuhito Imai ,Kenichi Yoshimura ,Alessandro Nasti ,Takashi Wada ,Noriho Iida ,Masaaki Kitahara ,Rika Horii ,Tamai Toshikatsu ,Masashi Nishikawa ,Hirofumi Okafuji ,Eishiro Mizukoshi ,Tatsuya Yamashita ,Taro Yamashita ,Kuniaki Arai ,Kazuya Kitamura ,Kazunori Kawaguchi ,Hajime Takatori ,Tetsuro Shimakami ,Takeshi Terashima ,Tomoyuki Hayashi ,Kouki Nio ,Shuichi Kaneko
肿瘤
胰腺癌
发表日期：2019
文献求助 收藏